(ALX) Alexanders - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0147521092
ALX: Office Space, Retail Space, Real Estate
Alexanders Inc. (NYSE: ALX) stands as a prominent real estate investment trust (REIT), incorporated in Delaware, with a focus on leasing, managing, developing, and redeveloping properties. As a REIT, it offers investors a unique avenue to gain exposure to the real estate market without direct ownership, aligning with the interests of both individual investors and fund managers seeking diversified portfolios.
The companys operational backbone is supported by Vornado Realty Trust (NYSE: VNO), a seasoned player in real estate, which oversees its management, leasing, and development activities. This partnership is significant, as Vornados expertise likely enhances Alexanders operational efficiency and strategic growth. Alexanders portfolio comprises five properties in New York City, a market known for its competitive landscape and high-value real estate, suggesting a strategic focus on prime locations that can drive substantial returns.
From a financial standpoint, Alexanders Inc. boasts a market capitalization exceeding $1 billion, indicating a substantial presence in the market. The price-to-earnings (P/E) ratio of 24.16 suggests that investors anticipate future growth, which could be attractive for those seeking capital appreciation. The price-to-book (P/B) ratio of 5.90 reflects a valuation that exceeds its book value, possibly due to market confidence in its management and asset quality. The price-to-sales (P/S) ratio of 4.47 indicates a moderate valuation relative to its revenue, which could be favorable for investors evaluating market positioning and competitive advantage.
Classified under Retail REITs, Alexanders Inc. is well-positioned in a niche market, potentially offering stability through long-term leases and the prospect of rental income growth. For investors and fund managers, this structure may provide a balanced risk-return profile, combining the stability of REITs with the growth potential of a dynamic real estate market like New York City.
Additional Sources for ALX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALX Stock Overview
Market Cap in USD | 1,078m |
Sector | Real Estate |
Industry | REIT - Retail |
GiC Sub-Industry | Retail REITs |
IPO / Inception | 1984-07-19 |
ALX Stock Ratings
Growth 5y | 8.55% |
Fundamental | 32.5% |
Dividend | 58.1% |
Rel. Strength | -3.73 |
Analysts | 2/5 |
Fair Price Momentum | 214.25 USD |
Fair Price DCF | 244.79 USD |
ALX Dividends
Dividend Yield 12m | 8.49% |
Yield on Cost 5y | 9.28% |
Annual Growth 5y | 0.00% |
Payout Consistency | 76.8% |
ALX Growth Ratios
Growth Correlation 3m | 81.9% |
Growth Correlation 12m | 3% |
Growth Correlation 5y | 14.7% |
CAGR 5y | 1.87% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | 0.23 |
Alpha | -1.92 |
Beta | 0.808 |
Volatility | 24.03% |
Current Volume | 11.5k |
Average Volume 20d | 12.9k |
As of April 03, 2025, the stock is trading at USD 212.85 with a total of 11,451 shares traded.
Over the past week, the price has changed by +0.70%, over one month by -0.59%, over three months by +10.91% and over the past year by +9.13%.
Neither. Based on ValueRay Fundamental Analyses, Alexanders is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.50 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALX as of April 2025 is 214.25. This means that ALX is currently overvalued and has a potential downside of 0.66%.
Alexanders has received a consensus analysts rating of 2.00. Therefor, it is recommend to sell ALX.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ALX Alexanders will be worth about 231.4 in April 2026. The stock is currently trading at 212.85. This means that the stock has a potential upside of +8.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 150 | -29.5% |
Analysts Target Price | 150 | -29.5% |
ValueRay Target Price | 231.4 | 8.7% |